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P2X receptors are trimeric cation channels that
open in response to binding of extracellular
ATP. Each subunit contains a large extracellular
ligand binding domain and two flanking trans-
membrane (TM) helices that form the pore, but
the extent of gating motions of the TM helices
is unclear. We probed thesemotions using iver-
mectin (IVM), a macrocyclic lactone that stabi-
lizes the open state of P2X4 receptor channels.
We find that IVM partitions into lipid mem-
branes and that transfer of the TM regions of
P2X4 receptors is sufficient to convey sensitiv-
ity to the lactone, suggesting that IVM interacts
most favorably with the open conformation of
the two TM helices at the protein-lipid interface.
Scanningmutagenesis of the two TMs identifies
residues that change environment between
closed and open states, and substitutions at
a subset of these positions weaken IVM bind-
ing. The emerging patterns point to widespread
rearrangements of the TM helices during open-
ing of P2X receptor channels.
INTRODUCTION
P2X receptor channels are a family of ligand-gated cation
channels that open in response to binding of ATP from the
extracellular side of the membrane (Khakh and North,
2006). The trimeric architecture of P2X receptors makes
them unique among other ligand-gated ion channels,
which are either pentamers (e.g., nicotinic acetylcholine
receptor channels) or tetramers (glutamate receptor chan-
nels) (Aschrafi et al., 2004; Barrera et al., 2005; Jiang et al.,
2003; Nicke et al., 1998; Stoop et al., 1999). In mammals
there are seven subtypes (termed P2X1–7) that are widely
expressed throughout the nervous system and in many
other tissues, including smooth muscle, epithelia, endo-
thelia, platelets, and bone. Each subunit is predicted to
have two transmembrane (TM) segments that are sepa-
rated by a large extracellular domain, with both N and Ctermini located on the intracellular side of the membrane
(Egan et al., 2006; North, 2002; Vial et al., 2004). The extra-
cellular domain contains the binding sites for ATP and
a number of other extracellular regulators (Vial et al.,
2004), and the oligomeric arrangement of the TM seg-
ments is thought to form a central ion conduction pore
(Egan et al., 1998; Haines et al., 2001b; Jiang et al.,
2001; Migita et al., 2001; Rassendren et al., 1997). TM1
and the external half of TM2 adopt a-helical secondary
structures (Li et al., 2004; Silberberg et al., 2005), and
both appear to move during gating (Egan et al., 1998;
Haines et al., 2001a, 2001b; Jiang et al., 2001; Li et al.,
2004; Rassendren et al., 1997; Silberberg et al., 2005),
although the nature and extent of their motions have not
been explored.
Ivermectin (IVM) is a semisynthetic macrocyclic lactone
that is widely used in humans and animals to treat nema-
tode infestations (Geary, 2005; Omura and Crump, 2004).
This general class of compounds, known as avermectins,
was discovered when testing fermentation products from
Streptomyces avermitilis for antiparasitic activity. The
therapeutic mechanism for IVM is thought to involve inter-
action with glutamate-gated Cl channels in the parasite,
leading to muscle paralysis and starvation (Cully et al.,
1994; Dent et al., 1997, 2000; Vassilatis et al., 1997). IVM
has been shown to activate glutamate-gated Cl channels
and to facilitate activation by glutamate, suggesting that
the lactone works through an allosteric mechanism (Arena
et al., 1995; Cully et al., 1994; Vassilatis et al., 1997). From
a biophysical perspective, IVM is fascinating because it in-
teracts with a wide variety of ligand-gated ion channels. In
addition to its therapeutic activity on glutamate-gated Cl
channels, IVM is an agonist and/or allosteric modulator of
GABA- and glycine-activated Cl channels (Adelsberger
et al., 2000; Shan et al., 2001; Sigel and Baur, 1987), a7
nicotinic acetylcholine receptor channels (Krause et al.,
1998), histamine receptor channels (Zheng et al., 2002),
and the P2X4 subtype of ATP-gated channels (Khakh
et al., 1999; Priel and Silberberg, 2004). In the case of
P2X4 receptor channels, single-channel analysis shows
that IVM stabilizes the open state of the channel relative
to both desensitized and closed states, which suggests
that the lactone binds more tightly to the open conforma-
tion of the channel (Priel and Silberberg, 2004). AlthoughNeuron 54, 263–274, April 19, 2007 ª2007 Elsevier Inc. 263
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gated ion channels might suggest a rather nonspecific
type of mechanism, there are counter examples where
IVM exhibits pronounced specificity between related ion
channels. For example, the P2X4 subtype of ATP-gated
channels exhibits robust sensitivity to IVM, whereas the
P2X2, P2X3, and P2X7 subtypes are IVM-insensitive
(Khakh et al., 1999). What type of mechanism could ex-
plain the targeting of distantly related ligand-gated ion
channels in the face of selectivity between highly related
channels? One possibility is that IVM interacts with re-
gions of the channel protein that are embedded in the lipid
membrane to produce a relative stabilization of the open
state of the channel. An interaction of IVM with the lipid
membrane might concentrate it near its receptor, stabilize
it on its receptor, or both, which are effects that could non-
specifically enhance apparent affinity of IVM for any chan-
nel protein that contains even amodest affinity receptor. If
this is the case, IVM could be used to probe the surfaces
of the TMs that face the lipid environment in the open
state. In the present study we explore whether the interac-
tion between IVM and P2X receptor channels occurs
within the plane of the membrane by localizing regions
of the channel that are necessary for IVM sensitivity using
a gain-of-function approach, and by testing whether IVM
can interact with phospholipid vesicles. We also use scan-
ning mutagenesis to identify mutations that influence IVM
occupancy at the protein-lipid interface in the open state.
Our results suggest that IVM facilitates activity of P2X re-
ceptor channels through an allosteric interaction within
the plane of themembrane and that both of the TM helices
extensively rearrange during opening of the pore.
RESULTS
The object of this studywas to test the hypothesis that IVM
modifies the gating of ion channels by interacting with TM
helices that are embedded in the membrane, and to then
use the lactone to explore movements of these helices
during gating of the channel. To study the interaction of
IVM with P2X receptor channels, P2X2, P2X4, and chi-
meras between these two subtypes were expressed in
Xenopus oocytes and studied using both electrophysio-
logical and biochemical approaches. The pronounced dif-
ference in sensitivity of P2X2 and P2X4 receptor channels
to IVM is illustrated in Figure 1C, where the continuous ap-
plication of 3 mM IVM to the extracellular solution for 5 min
has no effect on macroscopic membrane currents acti-
vated by a half-maximal concentration (EC50) of ATP in
the case of P2X2, but produces 4-fold facilitation of cur-
rents in the case of P2X4 (Khakh et al., 1999). Previous
studies using macroscopic and unitary channel recording
techniques have shown that IVM facilitates the activity of
P2X4 receptor channels through an allosteric mechanism
(Khakh et al., 1999; Priel and Silberberg, 2004). In single-
channel recordings, IVM prolongs burst duration and
mean open time, which point to a stabilization of the
open state relative to desensitized and closed states, re-264 Neuron 54, 263–274, April 19, 2007 ª2007 Elsevier Inc.spectively. Although it was recently proposed that IVM
facilitation of P2X4 receptor channels results from an
increase in the number of receptors on the cell surface
(Toulme´ et al., 2006), our results strongly suggest that
the actions of IVM are allosteric in nature and that the
lactone does not alter surface levels of P2X receptor
channels (see Figure S1 in the Supplemental Data).
IVM Interacts with TM Helices of P2X4
Receptor Channels
To initially explore the interaction of IVM with TM regions,
we performed gain-of-function experiments in attempts to
transfer IVM sensitivity between P2X4 and P2X2 (Fig-
ure 1C). Given the complex nature of allosteric interactions
in general, and the actions of IVM in particular (Priel and
Silberberg, 2004), as well as the potential for further com-
plexity with chimeric channels, we limited our analysis to
determining whether a given chimera is competent to
interact with IVM. An interaction of IVM with a particular
region of the channel would be supported if transferring
Figure 1. Differential Sensitivity of P2X Receptors to IVM
(A) Superimposed normalized current traces for P2X2 (left) and P2X4
(right) receptor channels. The bars above the current traces indicate
the duration of ATP application. The concentrations of ATP are 3, 10,
30, and 100 mM.
(B) Normalized concentration-response relationships for P2X2 (full cir-
cles) and for P2X4 (empty squares) receptor channels. Each point is the
mean ± SEM of four to five measurements. The EC50 and n estimated
from fitting the Hill equation to the P2X2 and P2X4 data are 38 ± 1 mM
(2.7 ± 0.2) and 11.8 ± 0.7 mM (1.5 ± 0.1), respectively.
(C) Continuous current traces recorded from an oocyte expressing
P2X2 (top) or P2X4 (bottom) receptor channels. Following a 5 s applica-
tion of an EC50 concentration of ATP, the oocyte was washed for 2 min
with control solution. IVM (3 mM) was then applied (indicated by open
bar above the current trace), and after 5 min an EC50 concentration of
ATP was applied again.
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Ivermectin Interaction with P2X Receptor ChannelsFigure 2. Sequence Alignment between
P2X2 and P2X4 Receptor Channels and
Chimeras Used to Identify Determinants
of IVM Sensitivity
(A) Sequence alignment of rat P2X2 and rat
P2X4 receptor channels; residues highlighted
in yellow are identical, and gray shaded resi-
dues are conserved. Rough demarcations of
TM1 and TM2 are indicated by horizontal
bars. Labeled arrowheads indicate the splice
sites for the various chimeras.
(B) Scaled schematic representation of a single
subunit of P2X2, P2X4, and the generated chi-
meras. Segments from P2X2 are in white and
segments from P2X4 are in green. The labeled
arrowheads correspond to the splice sites in
(A). The P4 chimera (asterisk) did not result in
functional channels. The corresponding EC50
and n estimated from fitting the Hill equation
to concentration-response relations for ATP
activation of the channels, and the fold effect
of IVM on the current (IIVM / IControl), are indi-
cated. ND indicates not determined.that region confers IVM sensitivity, although such experi-
ments would not rule out interactions of IVM with other
regions of the channel. To determine whether particular
chimeras are sensitive to IVM, we used an EC50 con-
centration of ATP and examined the effects of IVM at a
concentration that is saturating for WT P2X4 receptor
channels (3 mM; Figure 4D). Under these conditions, a
2-fold enhancement by IVM is anticipated if the channel
contains a competent IVM receptor and the channel has
a maximal Po approaching unity at saturating agonist con-
centrations. If themaximal Po is <1, the facilitating effect of
IVM could be >2-fold, as is the case for the WT P2X4 re-
ceptor channels where the maximal Po is around 0.2 (Priel
and Silberberg, 2004). Thus, we can conservatively con-
clude that a channel contains a competent IVM receptor
if IVM (3 mM) produces a R2-fold increase in current
when examined using an EC50 concentration of ATP.
Larger increases by IVM would indicate that the maximal
Po of the chimera is significantly less than unity. Insensitiv-
ity to IVM would indicate that either the chimera does not
contain a competent IVM receptor or that the closed,open, and desensitized states of the channel have equal
affinities for IVM, a possibility that seems remote. (The al-
losteric interactions between the closed-open equilibrium
and IVM stabilization of the open state are explored in
more depth in the final section of the Results).
We produced eight chimeras between these two P2X
receptor channels using five splice sites, and seven of
these gave rise to functional channels when expressed
in Xenopus oocytes (Figure 2). To test the feasibility of
a gain-of-function approach, we began by studying chi-
mera P1 in which both TMs and the entire extracellular do-
main of P2X2 were replaced with the equivalent regions
from P2X4. Chimera P1 displays an intermediate EC50
for ATP in comparison to the parent channels and is sen-
sitive to 3 mM IVM (Figure 2B; Figures 3A and 3B), suggest-
ing that the lactone interacts with the transferred regions
of P2X receptor channels. This observation is consistent
with previous results showing that intracellular application
of IVM does not modulate the activity of P2X4 receptor
channels (Priel and Silberberg, 2004), which suggests
that IVM does not bind to intracellular domains. We nextNeuron 54, 263–274, April 19, 2007 ª2007 Elsevier Inc. 265
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Ivermectin Interaction with P2X Receptor ChannelsFigure 3. IVM Sensitivity Can Be Transferred to P2X2 Receptor Channels
(A) Concentration-response relationship for chimera P1. The EC50 and n estimated from fitting the Hill equation to the data are 16 ± 4 mMand 0.9 ± 0.2,
respectively.
(B) Current traces for P2X4 (left pair) and chimera P1 (right pair) before (left trace of each pair) and after (right trace of each pair) 5 min exposure to 3 mM
IVM. The traces are shown such that the control currents are the same size.
(C) Concentration-response relationship for chimera P2. The EC50 and n are 0.5 ± 0.1 mM and 0.9 ± 0.1, respectively.
(D) Currents activated by ATP for chimera P2. In both pairs the left trace was obtained under control conditions. The right trace in each pair was
obtained without (left pair) or with (right pair) exposure to 3 mM IVM for 5 min. The control currents are the same size.
(E) Concentration-response relationships for chimera P3. The EC50 and n are 4.1 ± 0.4 mM and 2.2 ± 0.4, respectively.
(F) Concentration-response relationships for chimera P5. The EC50 and n are 16 ± 2 mM and 1.0 ± 0.1, respectively.
(G) Concentration-response relationships for chimera P6. The EC50 and n are 24 ± 5 mM and 1.1 ± 0.2, respectively.
Current trace insets for (E–G) show ATP-activated currents under control conditions (left trace) and after exposure to 3 mM IVM for 5 min (right trace).
Data points for all concentration-response relations are the mean ± SEM of four to five measurements.examined whether transfer of the large extracellular do-
main is sufficient to render P2X2 receptor channels sensi-
tive to IVM. In this P2 chimera, a brief application of ATP
results in significant desensitization, with only 26% ± 3%
(n = 4) of the current remaining after 7min of recovery (Fig-
ure 3D). The magnitude of the desensitized current is sim-
ilar in the presence of IVM (21% ± 4%; n = 4), indicating
that IVM sensitivity can not be transferred by the extracel-
lular domain alone (Figure 3D). To directly examine the role
of the TMs in IVM sensitivity, the two TMs of P2X4 were
transferred to P2X2, either individually or together. The
P3 chimera contains TM1 from P2X4 and is insensitive to
IVM (Figure 3E), and the P4 chimera contains TM2 from
P2X4 but does not result in functional channels (Figure 2).
The P5 chimera, containing TM2 plus a short segment of
the extracellular domain of P2X4, does result in functional
channels and displays a modest sensitivity (20% facilita-
tion) in response to IVM (Figure 3F). In contrast, a 2-fold
enhancement of current in response to IVM application
is observed in a chimera containing both TMs of P2X4 (chi-
mera P6; Figure 3G), indicating that transferring both TMs
of P2X4 into P2X2 is sufficient to transfer IVM sensitivity.
To further examine the requirement for both TMs, we
studied chimeras wherein the individual TMs were trans-
ferred separately along with the extracellular domain (Fig-266 Neuron 54, 263–274, April 19, 2007 ª2007 Elsevier Inc.ure2).Wecouldnot study theP7chimera,whichcontained
TM1 and the extracellular domain of P2X4, because it re-
quires several minutes to deactivate following activation
by 300 nM ATP; however, a chimera containing TM2 and
the extracellular domain of P2X4 (P8) displayed robust sen-
sitivity to IVM (Figure 2). The absence of TM1 of P2X4 from
chimera P8 indicates that transferring TM1 is not an abso-
lute requirement for the generation of IVM sensitivity, al-
though it does not rule out important interactions between
IVM and this TM1. Indeed, further mutagenesis experi-
ments described below support an interaction between
IVM and both TM1 and TM2. (See Discussion for further
elaboration of this issue.) The results with the P8 chimera
may also hint at an interaction of IVMwith the extracellular
ligand binding domain; however, it is also possible that this
domain indirectly influences how IVM interacts with the
two TMs. This possibility would be consistent with the P2
chimera (Figure 3), wherein transfer of the extracellular
domain does not transfer IVM sensitivity.
IVM Partitions in Membranes
To explore the possibility that IVM partitions into themem-
brane to interact with TM regions of the channel, we
evaluated the interaction of IVM with phospholipid
membranes using a spin-down assay. IVM (2 mM) was
Neuron
Ivermectin Interaction with P2X Receptor Channelsincubated for 5 min with or without large unilamellar vesi-
cles (LUVs) (6 mM) and the IVM remaining in the aqueous
phase after centrifugation was determined by reversed-
phase HPLC (RP-HPLC). Figure 4A shows superimposed
elusion profiles for IVM before (gray trace) and after (black
trace) incubation with vesicles containing a 1:1 mixture of
the zwitterionic 1-Palmitoyl-2-Oleoyl-sn-Glycero-3-Phos-
phocholine (POPC) and the anionic 1-Palmitoyl-2-Oleoyl-
sn-Glycero-3-[Phospho-rac-(1-glycerol)] (POPG). The
integral of the signal corresponding to IVM is 50% smaller
after incubation with phospholipid vesicles, indicating that
these vesicles can efficiently deplete the aqueous solution
of the lactone, with an estimated mole fraction partition
coefficient (Kx) of approximately 10
4 (White et al., 1998).
IVM also partitions into vesicles composed of POPC
alone, indicating that anionic lipids are not required for
partitioning (Figure 4B). In addition, the IVM analog dora-
mectin (DOM) partitions into mixed POPC:POPG vesicles
to an extent that is similar to that of IVM (Figure 4B),
consistent with the expectation that small chemical
differences in the lactones (see Figure 4C) would not dra-
matically alter partitioning. Taken together, these results
demonstrate that IVM and DOMpartition intomembranes,
consistent with the possibility that IVM interacts with
regions of P2X receptor channels that are embedded in
the membrane.
Distribution of Critical Moieties in the Structure
of Lactones
The results from our chimera studies raise the possibility
that the IVM receptor may be relatively large. Both NMR
and X-ray crystallographic analysis of IVM and avermectin
(AVM), a closely related analog, suggest they adopt rela-
tively extended conformations, spanning a distance of
20A˚ (Albers-Scho¨nberg et al., 1981; Hu et al., 1998;
Springer et al., 1981). To explore whether critical moieties
are distributed throughout the molecule, we examined
a series of available analogs (Figure 4C), including AVM,
DOM, and emamectin (EMM). AVM contains an olefinic
bond between carbons 22 and 23, whereas this position
is hydrated in IVM (X-Y bond in Figure 4C); DOM has a
cyclohexyl group at the R2 position in place of the aliphatic
moiety present in IVM; and EMMhas amethylamine group
at the R1 position in place of the hydroxyl group in IVM.
Examination of the activity of the IVM analogs shows
that the effects of IVM and AVM are comparable, but
that DOM and EMM have significantly smaller effects at
the highest concentrations the lactones remain soluble
(3 mM; Figure 4D). The moieties (R1 and R2) that differ be-
tween the lactones are located at the extreme ends of the
molecules, consistent with interaction of these com-
pounds with significant portions of both TMs.
Probing TM Helix Motions with IVM
The results thus far are compatible with the notion that
IVM interacts with regions of P2X receptor channels
(TM1 and TM2) that are submerged in the lipid mem-
brane. The open state stabilization by IVM observed inFigure 4. Membrane Partitioning of IVM and Structure-
Activity Relations for Lactone Analogs
(A) Superimposed RP-HPLC profiles of IVM remaining in the super-
natant without (gray trace) or after (black trace) 5 min incubation with
6mMPOPC/POPG vesicles. The dashed line indicates the percentage
of CH3CN in the elusion buffer.
(B) Fractional binding of IVM to lipid vesicles (mean ± SEM) determined
by measuring depletion of the lactone from aqueous solutions by ves-
icles composed of POPC or a 1:1 mix of POPC and POPG (POPC/G).
(C) Chemical structures of IVM, AVM, DOM, and EMM.
(D) Concentration-response relationships for the effects of IVM (full cir-
cles), AVM (empty squares), DOM (empty inverted triangles), and EMM
(empty triangles) on P2X4 receptor channel currents. Data points are
mean ± SEM for three to five measurements and the solid lines are
fits to the Hill equation. Current records shown to the right were acti-
vated by ATP (10 mM) before (left) and after (right) 5 min exposure to
3 mM of each of the lactones. Each pair of traces is from a different
oocyte.Neuron 54, 263–274, April 19, 2007 ª2007 Elsevier Inc. 267
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Ivermectin Interaction with P2X Receptor ChannelsFigure 5. Simulating the Activation of P2X Receptor
Channels by ATP and Their Facilitation by IVM According to
Scheme I
Po and normalized currents are shown in the left and right panels, re-
spectively. (A) The WT channel (black lines) and mutant channels in
which the gating equilibrium is perturbed 100-fold in favor of the closed
state (blue lines) or the open state (yellow lines). Note the profound re-
duction in maximal Po and minimal change in EC50 for a shift in the
equilibrium in favor of the closed state. (B–D) The effect of IVM (dashed
lines) on the WT channel (B), the mutant channel in which the C*-O
equilibrium is shifted in favor of O (C), and the mutant channel in which
the C*-O equilibrium is shifted in favor of C* (D). The predicted fold ef-
fects of IVM on current amplitude for an EC50 concentration of ATP for
each of the channels are depicted by the green arrows. Note the in-
creased effect of IVM for a shift in the equilibrium in favor of the closed
state. The rate constants (a, b, g, d) for the WT channel are 3.163 102,
13 103, 33 108, and 53 103 s1, respectively. These rates were cho-
sen to give a maximal Po of 0.24, EC50 of12.5 mM, and a mean chan-
nel open time of 1 ms in the absence of IVM. k and l of IVM are 103 and268 Neuron 54, 263–274, April 19, 2007 ª2007 Elsevier Inc.single-channel recordings (Priel and Silberberg, 2004)
would suggest that the lactone interacts most favorably
with the open conformation of the two TM helices. Our
final objective was to identify mutants within the TMs
that influence IVM occupancy at the protein-lipid interface
in the open state. Identifying such positions would have
important implications for the interaction of IVM with the
TM regions and for the rearrangements of the TMs during
opening of the channel, in particular when compared with
positions that are in more constrained environments in
either closed or open states. Our strategy for identifying
residues that influence IVM occupancy of the channel
arose from a conceptual model for the gating of P2X
receptor channels that involves distinct ATP binding and
opening transitions and IVM binding to the open state of
the channel (Scheme I):
For simplicity we include only a single ATP binding step
and a single opening transition, but the inclusion of multi-
ple ATP binding steps, a desensitized state, and IVM bind-
ing to multiple states do not qualitatively alter the key
predictions, so long as IVM binds most tightly to the
open state, as suggested by single-channel recordings
(Priel and Silberberg, 2004). Several important predictions
of Scheme I are illustrated in Figure 5 for instances where
mutations influence the equilibrium between C* andO, but
also where the channel remains competent to bind IVM.
Suppose that the TMs move so that some residues are
in more constrained environments in the closed state
compared with the open state, and other residues exhibit
an opposite change in environment. If a residue in ques-
tion is more buried in the protein in C* compared to O, mu-
tations would be expected to destabilize C* and shift the
C*-O transition toward the O state, in particular for inser-
tion of a bulky Trp. Conversely, if the residue is more bur-
ied in O compared with C*, mutations would be expected
to destabilize O and shift the C*-O transition toward C*.
(Here we negate the rare possibility that substitutions sta-
bilize a particular state.) The maximal open probability ob-
served from single-channel recordings is 0.2 (Priel and
Silberberg, 2004), indicating that the final C*-O transition
is biased toward C* in theWT channel. As a consequence,
mutations that shift C*-O toward O cause pronounced
shifts of the macroscopic ATP dose-response curve to
lower concentrations, whereas those that shift the equilib-
rium toward C* cause insignificant changes in the ATP
dose-response (Figure 5A). (Both types of perturbations
102 s1, respectively. The rates were chosen to give a 5-fold effect of
IVM on the WT channel and to increase mean channel open time
10-fold. Simulations were done in ChannelLab version 2.03.
Neuron
Ivermectin Interaction with P2X Receptor ChannelsFigure 6. Effects of TM1 Mutations on IVM Facilitation of P2X4 Receptor Channels
(A) Examples of ATP-activated current traces for each of the point mutations in TM1 under control conditions (left trace in each column) and 5minutes
after the addition of 3 mM IVM (right trace in each column). For eachmutant an EC50 concentration of ATPwas used (see Table S1). Traces were scaled
such that the larger of the currents in each pair are all the same size.
(B) Fold change in current amplitude induced by IVM for each of the point mutations in TM1 (mean ± SEM). The dashed line is the fold effect of IVM on
the WT channel. The solid red line indicates a 2-fold effect of IVM. Mutations with no current increase in IVM are in red. Mutations with R10-fold
increase in current in IVM are in blue. G45W was not studied because IVM activates this mutant channel in the absence of ATP.
(C) Estimated ATP EC50 values (± SEM) for point mutations in TM1. The dashed line is the estimated EC50 for the WT channel. Mutations with large
shifts in EC50 to lower ATP concentrations are colored yellow.
(D) Helical net diagram of TM1 (Silberberg et al., 2005). The residues highlighted in yellow exhibit large shifts in EC50 to lower ATP concentrations. The
residues highlighted in blue correspond to the point mutations that exhibit large increases in the effects of IVM on current amplitude. The residues with
red text and surrounding circle correspond to point mutations that significantly decrease the effect of IVM on current amplitude. V28 is crossed out to
indicate that a mutation to Trp results in nonconducting channels. W46 is hashed to indicate that mutation of this residue results in a shift in EC50 to
lower ATP concentrations, yet also a larger effect of IVM.alter maximal open probability, but these would not be de-
tected from macroscopic measurements.) If the mutation
shifts the C*-O transition toward O without altering IVM af-
finity, a saturating concentration of IVM (3 mM; Figure 4D)
should still facilitate the current by2-fold if the channel is
activated using a half-maximal concentration of ATP (Fig-
ure 5C). If the mutation shifts the C*-O transition toward C*
without altering IVM affinity, IVM should facilitate the cur-
rent by an amount larger than the 5-fold observed for the
WT channel (Figure 5D). Thus, two general conclusionscan be drawn from experiments where IVM facilitation is
examined using an EC50 concentration of ATP and satu-
rating concentrations of IVM. First, a mutation weakens
IVM affinity if the lactone facilitates macroscopic currents
<2-fold. Second, a mutation shifts the C*-O toward C* if
IVM enhances macroscopic currents by an amount
greater than that observed in the WT channel.
Using this approach we assessed facilitation by IVM for
Trp mutations throughout the TMs to look for mutations
that decrease IVM occupancy and those that shift C*-ONeuron 54, 263–274, April 19, 2007 ª2007 Elsevier Inc. 269
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Ivermectin Interaction with P2X Receptor ChannelsFigure 7. Effects of TM2 Mutations on IVM Facilitation of P2X4 Receptor Channels
(A) Examples of ATP-activated current traces for each of the point mutations in TM2 under control conditions (left trace in each column) and 5minutes
after the addition of 3 mM IVM (right trace in each column). For eachmutant an EC50 concentration of ATPwas used (see Table S2). Traceswere scaled
such that the larger of the currents in each pair are all the same size. Mutations of D354 and L358 to either Trp or Ala result in nonfunctional channels
and are thus not shown.
(B) Fold change in current amplitude induced by IVM for each of the point mutations in TM2 (mean ± SEM). The dashed line is the fold effect of IVM on
the WT channel. The solid red line indicates a 2-fold effect of IVM. Mutations with no current increase in IVM are in red. Mutations withR9.5-fold
increase in current in IVM are in blue.
(C) Estimated ATP EC50 values (± SEM) for point mutations in TM2. The dashed line is the estimated EC50 for the WT channel. Mutations with large
shifts in EC50 to lower ATP concentrations are colored yellow.
(D) Helical net diagram of TM2 (Silberberg et al., 2005). The residues highlighted in yellow exhibit large shifts in EC50 to lower ATP concentrations. The
residues highlighted in blue correspond to the point mutations that exhibit large increases in the effects of IVM on current amplitude. The residues with
red text and surrounding circle correspond to point mutations that significantly decrease the effect of IVM on current amplitude. Residues that are
crossed out are nonconducting when mutated to Trp. A349, L352, C353, and V357 were studied as mutations to Val or Ala. D354 and L358 were not
studied.toward C*. (In a few instances residues were mutated to
Ala or Val, either because Trp substitutions result in non-
functional channels or theWT residue is Trp.)We identified
five mutations in TM1 and four in TM2 where IVM is with-
out significant effect on the channel (red residues),
suggesting that these mutations lower IVM occupancy
(Figure 6 and Figure 7; see Tables S1 and S2 in the270 Neuron 54, 263–274, April 19, 2007 ª2007 Elsevier Inc.Supplemental Data). For these mutants we also examined
the effect of consecutive ATP applications in the absence
of IVM to determine whether residual desensitization
might mask the effects of IVM, as in the case of the
Y378A mutation (see Supplemental Materials). In each
case, however, the amplitude of consecutive ATP re-
sponses did not differ by more than 5% when the agonist
Neuron
Ivermectin Interaction with P2X Receptor Channelswas applied at 2 min intervals. The insensitivity of these
mutants to IVM does not imply that lactone binding is ab-
lated, but rather that IVM affinity is at least 10-fold lower
than that of the WT channel. Given the steep concen-
tration dependence for IVM facilitation (Figure 4D), a 10-
fold decrease in affinity would result in insignificant facili-
tation at the concentration of IVM tested (3 mM), in particu-
lar if one considers that themaximal effects of IVMmay be
only 2-fold for channels with a high maximal Po. Further
examination of the change in IVM affinity is not feasible
because concentrations >3 mM cannot be achieved under
our experimental conditions. In addition to mutations that
decrease IVMoccupancy, we discovered fivemutations in
TM1 and five in TM2 where IVM facilitation is dramatically
enhanced (blue residues), suggesting that these mutations
shift the C*-O equilibrium toward C* (Figure 6 and Figure 7;
Tables S1 and S2). The picture that emerges from the col-
lective results shown in Figure 6D and Figure 7D is that
many mutations shift C*-O toward O (yellow filled circles), a
subset of these decrease IVM affinity (red outlined circles),
and a nonoverlapping population of mutations shift C*-O
toward C* (blue filled circles). We observed only one
exception (W46A) that cannot be readily explained, an in-
stance where a Trp in WT was mutated to Ala (Figure 6).
The assumption that mutations shifting C*-O toward O are
more buried in C* fits quite nicely with the notion that
some of these residues influence IVM occupancy at the
protein-lipid interface in theOstate.The implicationof these
results is that both TM1 and TM2 undergo relatively wide-
spread rearrangements that alter the environment of a large
majorityof residues inbothTM1andTM2.Althoughasplay-
ing motion of the helices could account for the mutations
that shift the C*-O towardO, with some of these interacting
with IVMat theprotein-lipid interface, thedistributionofmu-
tations in TM1 that shift C*-O toward C* implies a rotational
component for the motion during opening (Figure 8).
DISCUSSION
One of the motivations of the present study was to under-
stand how IVM can influence unrelated ligand-gated ion
channels in a rather promiscuous fashion, yet distinguish
between closely related ion channels, as in the case of
P2X4 and P2X2 receptor channels (Figure 1). Our hypoth-
esis was that an interaction of IVM within the plane of the
membrane might help to explain this paradox. Previous
electrophysiological studies suggest that IVM facilitates
the activity of P2X4 receptor channels through an allosteric
mechanism (Khakh et al., 1999; Priel and Silberberg,
2004), an idea strongly supported by our experiments
showing that IVM does not alter the number of channels
on the cell surface (see Supplemental Materials). The chi-
meras studied here show that transferring either extracel-
lular or intracellular domains does not render the recipient
channel IVM-sensitive, whereas transferring both TMs of
P2X4 into P2X2 is sufficient to transfer sensitivity to the lac-
tone (Figure 3). Although these results do not preclude an
interaction of IVM with other regions of the protein, asthese may already be competent to contribute to the re-
ceptor for IVM, they are consistent with an interaction of
the lactone with both TMs. In addition, scanningmutagen-
esis of TM1 and TM2 supports an interaction of IVM with
both TMs, as many mutations in these helices have pro-
nounced effects on IVM facilitation (Figure 6 and Figure 7).
In studying a number of IVM analogs, we also found that
modifications in distributed regions of the lactone have
pronounced effects on activity (Figure 4), which is consis-
tent with the notion that IVM interacts with a receptor that
is of similar dimensions, possibly including significant por-
tions of both TMs.
The idea of IVM interacting with TM helices is also sup-
ported by experiments showing that IVM can partition into
model membranes with reasonably strong energetics (Kx
104), regardless of whether the membranes contain
anionic or zwitterionic lipids (Figure 4). The similar parti-
tioning of IVM into anionic and zwitterionic membranes
favors the possibility that IVM can partition into native
membranes where the outer leaflet has a preponderance
of zwitterionic lipids (Calderon and DeVries, 1997; Hill
et al., 2005; Simons and van Meer, 1988). Partitioning of
IVM into membranes is consistent with studies with fluo-
rescently labeled IVM (bodipy-IVM), which in parasites
has been shown to accumulate in muscle membranes
(Martin and Kusel, 1992). Given that IVM partitions into
the membrane, is it possible that the effects of the lactone
are mediated indirectly through perturbations of the prop-
erties of the lipid bilayer? This type of mechanism has
been proposed for GsMTx, a protein toxin that inhibits
stretch-activated channels (Suchyna et al., 2004). The in-
teraction of IVM with P2X receptor channels exhibits pro-
nounced selectivity, both in terms of the lactone (Figure 4)
and the channel (Figure 1), supporting the notion that the
lactones actually bind to the channel. In addition, both
IVM and DOM partition into membranes (Figure 4), yet
DOM has less pronounced effects on the activity of
P2X4 receptor channels compared with IVM (Figure 4).
Our working model for IVM interaction with P2X recep-
tors is illustrated in Figure 8, where the lactone partitions
into the membrane and interacts with the two TMs at the
lipid-protein interface. The trimeric architecture of P2X re-
ceptor channels (Aschrafi et al., 2004; Barrera et al., 2005;
Jiang et al., 2003; Nicke et al., 1998; Stoop et al., 1999),
together with IVM binding peripherally at the protein-lipid
interface, raises the possibility that there are three IVM
binding sites per channel. The steep concentration-
response relations observed for IVM and AVM (Figure 4)
can only be explained by multiple occupancy of the chan-
nel by the lactones, consistent with this possibility. There
are several reasons for thinking that IVM binds in a crevice
formed at the interface between TM1 and TM2, and that it
is the rough shape and hydrophobic character of the crev-
ice that is most important for IVM binding. First, mutations
in both TMs weaken IVM affinity, and in most of these in-
stances the mutation changes a moderately sized hydro-
phobic residue to Trp (two are actually Gly to Trp), which
suggests that some of thesemutants may weaken bindingNeuron 54, 263–274, April 19, 2007 ª2007 Elsevier Inc. 271
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a side chain that interacts in a specific fashion with the lac-
tone. Second, the notion of IVM binding in a hydrophobic
crevice would explain how the lactone can interact with
other unrelated ligand-gated ion channels in addition to
P2X receptor channels. Finally, an IVM receptor of this
type would also help to explain some of the complexities
in our results with chimeras and point mutations. Although
themutagenesis of TM1 and TM2 support an interaction of
IVM with both TMs (as do results with chimeras P1, P2,
and P6), transferring TM2 along with the extracellular do-
main is sufficient to confer IVM sensitivity, even though
transferring the extracellular domain alone is not. It is as
if TM1 from either P2X2 or P2X4 can contribute to the
IVM receptor, but only if present along with either the ex-
tracellular domain or TM2 of P2X4. These results would be
perplexing if there were many specific interactions be-
tween crucial moieties in IVM with side chains in the TM
regions, but not if the minimal requirements for competent
IVMbinding are the rough shape and hydrophobic charac-
ter of the TM1/TM2 crevice. In this case, the extracellular
agonist binding domain might influence IVM binding indi-
rectly by altering the shape of the hydrophobic TM1/TM2
crevice. The affinity of IVM for the hydrophobic crevice
could be quite low (e.g., mM) because the membrane
could serve to concentrate the lactone near its receptor.
If the Kx values determined here for partitioning into model
membranes reflect the energetics of partitioning into na-
tive cellular membrane, then the effective concentration
of IVM could be two to three orders of magnitude higher
than the mMconcentrations present in the aqueous phase.
(The membrane might also provide a stabilizing influence,
in effect, constituting part of the receptor for IVM itself.)
The interaction of IVM with P2X receptor channels proba-
bly occurs within the outer half of the bilayer, as all but one
of the mutants that weaken IVM binding are located in the
outer halves of TM1 and TM2, and because the lactone is
Figure 8. A Proposed Model for the Gating of P2X4 Receptor
Channels and Their Modulation by IVM
TM1 is proposed to rotate relative to TM2 during gating, exposing res-
idues that are buried in the closed state to the lipid environment in the
open state (yellow face of the helix). This rotation enables optimal bind-
ing of IVM in a crevice at the protein-lipid interface. A related motion
may also occur for TM2, although the patterns are less clear in this
case, in part because the secondary structure for the internal portion
of this segment is unresolved.272 Neuron 54, 263–274, April 19, 2007 ª2007 Elsevier Inc.only active when applied from the extracellular side of the
membrane (Priel and Silberberg, 2004; see also Martin
and Kusel, 1992).
There are two features of the interaction of IVMwith P2X
receptor channels that make the lactone a particularly
powerful tool for understanding the motions of the pore
during gating. First, interaction of IVM with the TMs of
P2X receptor channels at the protein-lipid interfacemeans
that residues interacting with the lactone would be posi-
tioned at the protein-lipid interface in the open state. We
identified five positions in TM1 and four in TM2 where
IVM did not increase current amplitude (Figure 6 and Fig-
ure 7; red residues). Remarkably, each of these mutants
also exhibit enhanced sensitivity to ATP (Figure 6 and Fig-
ure 7; yellow highlighting), suggesting that they shift the
C*-O transitions toward O because they are in more con-
strained environments in C* compared with O. The consis-
tent picture is that these residues move during opening
from a buried location (in the protein) to facing the sur-
rounding lipid where they influence the local binding of
IVM. The second useful feature of IVM is that the lactone
can detect mutations that shift the C*-O equilibrium
toward C* because the lactone should facilitate macro-
scopic currents more dramatically in such mutants (Fig-
ure 5). The C*-O transition appears to be already biased
toward C* in the WT P2X4 receptor channel (maximal Po
0.2), and therefore mutations shifting the equilibrium fur-
ther toward C* would not show dramatic changes in the
concentration dependence for activation by ATP (Fig-
ure 5). We identified ten mutations in the two TMs that ex-
hibit significantly greater effects of IVM (at saturating con-
centrations) compared with the WT channel (Figure 6 and
Figure 7; blue residues). Most of these mutants have EC50
values for ATP within 2-fold of that of the WT channel, and
thus the underlying perturbation of the opening transition
would not be detectable from macroscopic measure-
ments without the aid of IVM. The mutants that shift
C*-O toward C* are likely to be in more constrained envi-
ronments in O compared with C*, which is opposite to
the environmental change for those residues that shift
the equilibrium toward O. Inspection of the collective re-
sults (Figure 6 and Figure 7) for mutations that decrease
IVM occupancy (red circled residues), shift C*-O toward
C* (enhanced IVM sensitivity; blue residues), and shift
C*-O toward O (enhanced sensitivity to ATP; yellow resi-
dues) leaves the general impression that the structural
rearrangements of the TM regions during opening of the
channel must be quite distributed, and likely involve exten-
sive repacking and motions of both TM helices. Without
the mutants shifting C*-O toward C*, the result could be
explained by a splaying apart of the helices during open-
ing, with IVM intercalating between helices in the O state.
However, the distribution of mutations that shift C*-O
toward C* suggests a rotational component of the TM
motions during opening. This type of gatingmotion is illus-
trated in Figure 8, where the yellow faces of the TM1 heli-
ces rotate out toward the lipid environment with opening,
enabling optimal IVM binding. A related motion may also
Neuron
Ivermectin Interaction with P2X Receptor Channelsoccur for TM2, although the patterns are less clear in this
case, in part because the secondary structure for the inter-
nal portion of this segment is unresolved (Li et al., 2004;
Silberberg et al., 2005).
EXPERIMENTAL PROCEDURES
Mutagenesis
Rat P2X2 cDNA in pcDNA1 was generously provided by Dr. David
Julius (University of California, San Francisco). Rat P2X4 cDNA in
pcDNA3 (generously provided by Dr. Florentina Soto, Max-Planck
Institute for Experimental Medicine, Go¨ettingen, Germany) was sub-
cloned into pGEM-HE vector (Liman et al., 1992) to improve expres-
sion in oocytes. Chimera and mutant P2X channels were generated
using polymerase chain reactions (PCR) with either P2X2 or P2X4
cDNA as templates. The sequence of all constructs was confirmed
by automated DNA sequencing and cRNA was synthesized using T7
polymerase after linearizing the DNA with XbaI.
Electrophysiological Recording
Wild-type, chimera, and mutant channels were expressed in Xenopus
oocytes by injecting approximately 50 nl of cRNA per oocyte at differ-
ent dilutions. Membrane currents were recorded under voltage-clamp
using an OC-725C oocytes clamp amplifier (Warner Instrument Corp.)
and digitized using a Digidata 1321A interface board and pCLAMP 9
software (Axon Instruments). The sampling frequency was set to at
least two times the corner frequency of the low-pass filter. To minimize
voltage-clamp errors, the maximal current recorded from each chi-
mera was limited by adjusting the amount of cRNA injected, the time
between cRNA injection and current recording, and the holding volt-
age (80 to 30 mV). The recording solution contained 100 mM
NaCl, 5 mM HEPES, 1 mM MgCl2, and 0.3 mM CaCl2 (pH 7.6). Stock
solutions (10 mM) of IVM, AVM, DOR, and EMA (Sigma) were prepared
in DMSO and maintained at 20C. The final DMSO concentration in
the experimental solutions was % 0.1%. Solutions containing ATP
were prepared freshly each day and the pH of the solution was read-
justed to 7.6.
Concentration-response relationships for ATP activation of each
construct were obtained by measuring macroscopic currents in re-
sponse to ATP application. A reference concentration of ATP was ap-
plied first to each oocyte, and 2 min later a single test concentration
was applied and the response was normalized to the reference con-
centration. Each concentration was tested on at least four oocytes,
and all oocytes used to generate a concentration-response relation-
ship were from the same batch. The Hill equation was fit to concentra-
tion-response relationships using SigmaPlot 2000 software (SPSS
Inc.) according to
I
Imax
=
½ATPn
½ATPn +ECn50
where I is the normalized current at a given concentration of ATP, Imax
is the maximum normalized current, EC50 is the concentration of ATP
([ATP]) yielding a current half the maximum, and n is the Hill coefficient.
Membrane Partitioning
The interaction of IVM with LUVs was examined by incubating IVM
(2 mM) with vesicles (6 mM) at room temperature for 5 min, separating
the vesicles by centrifuging (100,000 3 g, 5C) in polyallomer centri-
fuge tubes (Beckman) for 20 min, and determining the IVM concentra-
tion remaining in the aqueous phase. LUVs were prepared by drying
lipids under nitrogen gas, washing the lipid pellet with pentane, and
resuspending it by vortexing for 30 min in recording solution. Vesicles
were prepared using either POPC or a 1:1 mixture of POPC and POPG
and extruded 15 times using 0.1 mm polycarbonate filters (Avanti Polar
Lipids, Inc.). To minimize the loss of IVM from the solution due to non-specific adhesion to the surface of the tube, siliconized tubes were
preincubated with 2 mM IVM for 60 min. Aqueous concentrations of
IVM (following separation of vesicles by centrifugation) were deter-
mined using RP-HPLC with an ODS (C-18) column (4.6 3 250 mm;
5 mm, 90 A˚). IVMwas eluted with a linear gradient of 80%–100%mobile
phase B over 30 min at 1 ml/min, where mobile phase A was 0.1%
trifluoroacetic acid (TFA) in water and mobile phase B was 0.08%
TFA in acetonitrile. Mole fraction partitioning coefficients (Kx) were
calculated according to
Kx =
ð½IVMtotal ½IVMfreeÞ=½L
½IVMfree=½W
where [L] and [W] are the molar concentration of lipid and water,
respectively, and [IVM]total and [IVM]free are the aqueous IVM concen-
trations measured after centrifugation in the absence or presence of
liposomes, respectively (White et al., 1998).
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/54/2/263/DC1/.
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